Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard C Herrmann

Showing results (121-130 of 306) with videos related to

Pageof 31
Sort By:
Journal of the American Heart Association|June 29, 2017
Transcatheter Aortic Valve Implantation With or Without Percutaneous Coronary Artery Revascularization Strategy: A Systematic Review and Meta-AnalysisRafail A Kotronias, Chun Shing Kwok, Sudhakar George, et al.
Clinical Therapeutics|September 21, 2002
A multicenter study of the tolerability of tirofiban versus placebo in patients undergoing planned intracoronary stent placementCraig P Juergens, Harvey D White, Jorge A Belardi, et al.
JACC. Cardiovascular Interventions|June 24, 2017
Permanent Pacemaker Implantation Following Transcatheter Aortic Valve ReplacementDanielle C Savino, Fenton H McCarthy, Danielle D Spragan, et al.
Circulation. Cardiovascular Interventions|July 17, 2014
Factors associated with vascular complications in patients undergoing balloon-expandable transfemoral transcatheter aortic valve replacement via open versus percutaneous approachesMitul B Kadakia, Howard C Herrmann, Nimesh D Desai, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Cardiology Assessment of Patients Undergoing Evaluation for Orthotopic Liver TransplantationMichael S Lee, Subeer Wadia, Yerem Yeghiazarians, et al.
Journal of the American College of Cardiology|May 14, 2013
4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitationLaura Mauri, Elyse Foster, Donald D Glower, et al.
Circulation. Cardiovascular Quality and Outcomes|September 12, 2013
How to define a poor outcome after transcatheter aortic valve replacement: conceptual framework and empirical observations from the placement of aortic transcatheter valve (PARTNER) trialSuzanne V Arnold, John A Spertus, Yang Lei, et al.
European Heart Journal|August 19, 2005
Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-upDebabrata Mukherjee, Eric J Topol, Michel E Bertrand, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 22, 2014
Rationale, development, implementation, and initial results of a fast track protocol for transfemoral transcatheter aortic valve replacement (TAVR)Rebecca Marcantuono, Jacob Gutsche, Maureen Burke-Julien, et al.
JACC. Cardiovascular Interventions|August 20, 2018
The Effect of Post-Dilatation on Outcomes in the PARTNER 2 SAPIEN 3 RegistryRebecca T Hahn, Philippe Pibarot, Jonathon Leipsic, et al.
Pageof 31

Showing results (121-130 of 306) with videos related to

Sort By:
Pageof 31
Journal of the American Heart Association|June 29, 2017
Transcatheter Aortic Valve Implantation With or Without Percutaneous Coronary Artery Revascularization Strategy: A Systematic Review and Meta-AnalysisRafail A Kotronias, Chun Shing Kwok, Sudhakar George, et al.
Clinical Therapeutics|September 21, 2002
A multicenter study of the tolerability of tirofiban versus placebo in patients undergoing planned intracoronary stent placementCraig P Juergens, Harvey D White, Jorge A Belardi, et al.
JACC. Cardiovascular Interventions|June 24, 2017
Permanent Pacemaker Implantation Following Transcatheter Aortic Valve ReplacementDanielle C Savino, Fenton H McCarthy, Danielle D Spragan, et al.
Circulation. Cardiovascular Interventions|July 17, 2014
Factors associated with vascular complications in patients undergoing balloon-expandable transfemoral transcatheter aortic valve replacement via open versus percutaneous approachesMitul B Kadakia, Howard C Herrmann, Nimesh D Desai, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Cardiology Assessment of Patients Undergoing Evaluation for Orthotopic Liver TransplantationMichael S Lee, Subeer Wadia, Yerem Yeghiazarians, et al.
Journal of the American College of Cardiology|May 14, 2013
4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitationLaura Mauri, Elyse Foster, Donald D Glower, et al.
Circulation. Cardiovascular Quality and Outcomes|September 12, 2013
How to define a poor outcome after transcatheter aortic valve replacement: conceptual framework and empirical observations from the placement of aortic transcatheter valve (PARTNER) trialSuzanne V Arnold, John A Spertus, Yang Lei, et al.
European Heart Journal|August 19, 2005
Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-upDebabrata Mukherjee, Eric J Topol, Michel E Bertrand, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 22, 2014
Rationale, development, implementation, and initial results of a fast track protocol for transfemoral transcatheter aortic valve replacement (TAVR)Rebecca Marcantuono, Jacob Gutsche, Maureen Burke-Julien, et al.
JACC. Cardiovascular Interventions|August 20, 2018
The Effect of Post-Dilatation on Outcomes in the PARTNER 2 SAPIEN 3 RegistryRebecca T Hahn, Philippe Pibarot, Jonathon Leipsic, et al.
Pageof 31